LANGE LOUIS G bought NAMS
February 13, 2024 · Form 4 insider transaction
LANGE LOUIS G bought 5,000 shares of NewAmsterdam Pharma Company N.V. at $19.00 per share, a transaction worth $95.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 8 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$19.00
Total value
$95.0K
InsiderLANGE LOUIS G
RoleDirector
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateFebruary 13, 2024
Filing dateFebruary 21, 2024
Shares owned after24,878
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Represents ordinary shares acquired from the Company in an underwritten public offering. The ordinary shares acquired from the Company were placed into and are being held in a trust account for the benefit of the Reporting Person.